Accelerating the Dissemination and Translation of Clinical Research into Practice
This presentation is the property of its rightful owner.
Sponsored Links
1 / 5

Opening Remarks: Dr. Griffin Rodgers PowerPoint PPT Presentation


  • 72 Views
  • Uploaded on
  • Presentation posted in: General

Accelerating the Dissemination and Translation of Clinical Research into Practice. The Following Faculty have No Relevant Financial Relationships with Commercial Interests. Opening Remarks: Dr. Griffin Rodgers. Examples of Translation Efforts in NIDDK. Griffin P. Rodgers, M.D., M.A.C.P.

Download Presentation

Opening Remarks: Dr. Griffin Rodgers

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Accelerating the Dissemination and Translation of Clinical Research into Practice

The Following Faculty have No Relevant Financial Relationships

with Commercial Interests

Opening Remarks: Dr. Griffin Rodgers


Examples of Translation Efforts in NIDDK

Griffin P. Rodgers, M.D., M.A.C.P.

Director, National Institute of Diabetes and

Digestive and Kidney Diseases

May 9, 2008


Progress in Prevention:The DPP and NDEP

The Diabetes Prevention Program Study

National Diabetes Education Program

Campaign Goal: translate DPP results into practice

Critical finding: Prevention is achievable for many people at-risk for type 2 diabetes

  • Provides DPP-proven tools for lifestyle change to those at high risk of diabetes and their health care providers

  • Sponsored by NIDDK, CDC and 200 partners

  • Lifestyle modification intervention lowered risk of diabetes by 58%.

  • Metformin lowered diabetes risk by 31%.


Diabetes Research and Dissemination Spectrum

“Bench to Bedside and Beyond”


  • Login